Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02945254
Other study ID # 2016P000982
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received
Last updated
Start date August 2016
Est. completion date February 2017

Study information

Verified date May 2018
Source Brigham and Women's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Insufficient and low-quality sleep is a major public health problem that has been linked to motor vehicle crashes, industrial disasters, and medical and other occupational errors. Persons experiencing sleep insufficiency are also more likely to suffer from chronic diseases such as hypertension, diabetes, depression, and obesity, as well as from cancer, increased mortality, and reduced quality of life and productivity.

The number of people using sleep-inducing drugs to increase or improve sleep is steadily increasing in the last few decades; however, the side effects of these therapies often outweigh the benefits.

A few small trials and anecdotal findings suggest that continuous background (pink or white) noise overnight can improve sleep quality, increase acoustic arousal threshold, and reduce sleep onset latency.

In an attempt to find new, alternative solutions to increase sleep quality in people suffering from insomnia, the investigators would like to test the effect of surrounding filtered white noise on sleep onset latency and subjective sleep quality in healthy subjects.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date February 2017
Est. primary completion date February 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 60 Years
Eligibility Inclusion Criteria:

- Age between 21 and 60

Exclusion Criteria:

- Any sleep disorder

- Use of hypnotics

Study Design


Related Conditions & MeSH terms


Intervention

Device:
NIghtingale (R) device for filtered white noise (Cambridge Sound Management, Waltham, MA)


Locations

Country Name City State
United States Sleep Disorders Research Program Brigham and Women's Hospital Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Brigham and Women's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sleep Onset Latency (Mins) time from lights out to the first epoch of stage 2 NREM sleep 1 night
Secondary Subjective Sleep Quality (VAS) subjective sleep quality was assessed in the morning with a visual analog scale (VAS) ranging from 1 (worse quality) to 10 (best quality) 1 night
See also
  Status Clinical Trial Phase
Recruiting NCT01393574 - Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties Phase 4